Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

With the increased worldwide burden of cancer, including aggressive and resistant cancers, oncolytic virotherapy has emerged as a viable therapeutic option. Oncolytic herpes simplex virus (oHSV) can be genetically engineered to target cancer cells while sparing normal cells. This leads to the direct...

詳細記述

書誌詳細

主要な著者:	Norah Aldrak, Sarah Alsaab, Aliyah Algethami, Deepak Bhere, Hiroaki Wakimoto, Khalid Shah, Mohammad N. Alomary, Nada Zaidan
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2021-06-01
シリーズ:	Cells
主題:	oncolytic herpes simplex virus (oHSV) virotherapy immunotherapy cancer
オンライン･アクセス:	https://www.mdpi.com/2073-4409/10/6/1541
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!